In silico toxicity investigation of Methaqualone’s conjunctival, retinal, and gastrointestinal hemorrhage by molecular modelling approach

References

• Ionescu-Pioggia M, Bird M, Orzack MH, et al. Methaqualone. Int Clin Psychopharmacol. 1988;3(2):97–109. doi:10.1097/00004850-198804000-00001.
   PubMed Web of Science ®Google Scholar
• Hammer H, Bader BM, Ehnert C, et al. A Multifaceted GABAA Receptor Modulator: Functional Properties and Mechanism of Action of the Sedative-Hypnotic and Recreational Drug Methaqualone (Quaalude). Mol Pharmacol. 2015;88(2):401–420. doi:10.1124/mol.115.099291.
   PubMed Web of Science ®Google Scholar
• van Zyl EF. A survey of reported synthesis of methaqualone and some positional and structural isomers. Forensic Sci Int. 2001;122(2-3):142–149. doi:10.1016/s0379-0738(01)00484-4.
   PubMed Web of Science ®Google Scholar
• Lewis JR, Steindler EM. Methaqualone. JAMA. 1973;224(11):1521–1522. doi:10.1001/jama.1973.03220250043015.
   PubMed Web of Science ®Google Scholar
• Holstege CP. Methaqualone. Encyclopedia of Toxicology. 2005;2:297–298.
   Google Scholar
• Majelyne W, De Clerck F, Demeter J, et al. Treatment evaluation of a severe methaqualone intoxication in man. Vet Hum Toxicol. 1979;21 Suppl:201–204.
   PubMedGoogle Scholar
• Matthew H, Proudfoot AT, Brown SS, et al. Mandrax poisoning: conservative management of 116 patients. Br Med J. 1968;2(5597):101–102. doi:10.1136/bmj.2.5597.101.
   PubMedGoogle Scholar
• Dowd P, Ham SW, Naganathan S, et al. The mechanism of action of vitamin K. Annu Rev Nutr. 1995;15:419–440. doi:10.1146/annurev.nu.15.070195.002223.
   PubMed Web of Science ®Google Scholar
• Liu S, Li S, Shen G, et al. Structural basis of antagonizing the vitamin K catalytic cycle for anticoagulation. Science. 2021;371(6524):eabc5667, doi:10.1126/science.abc5667.
   PubMed Web of Science ®Google Scholar
• Chen X, Liu Y, Furukawa N, et al. A novel vitamin K derived anticoagulant tolerant to genetic variations of vitamin K epoxide reductase. J Thromb Haemost. 2021;19(3):689–700. doi:10.1111/jth.15209.
   PubMed Web of Science ®Google Scholar
• Rishavy MA, Berkner KL. Insight into the coupling mechanism of the vitamin K-dependent carboxylase: mutation of histidine 160 disrupts glutamic acid carbanion formation and efficient coupling of vitamin K epoxidation to glutamic acid carboxylation. Biochemistry. 2008;47(37):9836–9846. doi:10.1021/bi800296r.
   PubMed Web of Science ®Google Scholar
• Jackson CM, Suttie JW. Recent developments in understanding the mechanism of vitamin K and vitamin K-antagonist drug action and the consequences of vitamin K action in blood coagulation. Prog Hematol. 1977;10:333–359.
   PubMedGoogle Scholar
• Michelson AD. New P2Y12 antagonists. Curr Opin Hematol. 2009;16(5):371–377. doi:10.1097/MOH.0b013e32832ea2f2.
   PubMedGoogle Scholar
• Mills DG. Effects of methaqualone on blood platelet function. Clin Pharmacol Ther. 1978;23(6):685–691. doi:10.1002/cpt1978236685.
   PubMed Web of Science ®Google Scholar
• Ramakers C, van der Heul C, van Wijk EM. Stollingsonderzoek: PT en APTT [Investigation of coagulation time: PT and APTT]. Ned Tijdschr Geneeskd. 2012;156(0):A3985.
   PubMedGoogle Scholar
• Smith SA, Travers RJ, Morrissey JH. How it all starts: Initiation of the clotting cascade. Crit Rev Biochem Mol Biol. 2015;50(4):326–336. doi:10.3109/10409238.2015.1050550.
   PubMed Web of Science ®Google Scholar
• Dahlbäck B. Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders. Int J Lab Hematol. 2016;38 Suppl 1:4–11. doi:10.1111/ijlh.12508.
   PubMed Web of Science ®Google Scholar
• Zrieq R, Ahmad I, Snoussi M, et al. Tomatidine and Patchouli Alcohol as Inhibitors of SARS-CoV-2 Enzymes (3CLpro, PLpro and NSP15) by Molecular Docking and Molecular Dynamics Simulations. Int J Mol Sci. 2021;22(19):10693. Published 2021 Oct 2, doi:10.3390/ijms221910693.
   PubMed Web of Science ®Google Scholar
• Pawara R, Ahmad I, Nayak D, et al. Novel, selective acrylamide linked quinazolines for the treatment of double mutant EGFR-L858R/T790M Non-small-cell lung cancer (NSCLC). Bioorg Chem. 2021;115:105234, doi:10.1016/j.bioorg.2021.105234.
   PubMed Web of Science ®Google Scholar
• Cattaneo M. P2y12 receptors: structure and function. J Thromb Haemost. 2015;13:S10–S16. doi:10.1111/jth.12952.
   PubMed Web of Science ®Google Scholar
• Patel H, Ansari A, Pawara R, et al. Design and synthesis of novel 2,4-disubstituted aminopyrimidines: reversible non-covalent T790M EGFR inhibitors. J Recept Signal Transduct Res. 2018;38(5-6):393–412. doi:10.1080/10799893.2018.1557207.
   PubMed Web of Science ®Google Scholar
• Patel H, Ahmad I, Jadhav H, et al. Investigating the impact of different acrylamide (electrophilic warhead) on osimertinib’s pharmacological spectrum by molecular mechanic and quantum mechanic approach. Comb Chem High Throughput Screen. 2021;25(1):149–166. doi:10.2174/1386207323666201204125524.
   Web of Science ®Google Scholar
• Ahmad I, Akand SR, Shaikh M, et al. Synthesis, molecular modelling study of the methaqualone analogues as anti-convulsant agent with improved cognition activity and minimized neurotoxicity. J Mol Struct. 2022;1251:131972.
   Web of Science ®Google Scholar
• Pawara R, Ahmad I, Nayak D, et al. Design and synthesis of the novel, selective WZ4002 analogue as EGFR-L858R/T790M tyrosine kinase inhibitors for targeted drug therapy in non-small-cell lung cancer (NSCLC). J Mol Struct. 2022;1254:132313.
   Web of Science ®Google Scholar
• Pawara R, Ahmad I, Surana S, et al. Computational identification of 2,4-disubstituted amino-pyrimidines as L858R/T790M-EGFR double mutant inhibitors using pharmacophore mapping, molecular docking, binding free energy calculation, DFT study and molecular dynamic simulation. In Silico Pharmacology. 2021;9(1):54. Published 2021 Oct 6, doi:10.1007/s40203-021-00113-x.
   PubMedGoogle Scholar